Extremely aggressive and almost always unresectable
Large, heterogeneous, moderately enhancing, exophytic mass with necrosis and cystic change
•
Small cell carcinoma
Highly aggressive, with hematologic and lymphatic metastases at time of diagnosis
Large, homogeneous, mildly enhancing mass with confluent local and distant lymphadenopathy
May be indistinguishable from lymphoma
•
Giant cell carcinoma (pleomorphic or osteoclast)
Resection often impossible due to large size
Large, heterogeneous, cystic, low-density mass with frequent hemorrhage, septation, and calcification
•
Acinar cell carcinoma
Slightly better prognosis than adenocarcinoma
Large, well-circumscribed mass with cystic degeneration, exophytic component, and enhancing capsule
Usually no biliary/pancreatic duct dilatation
Vascular occlusion uncommon (20%); may invade the portal vein/superior mesenteric vein
•
Pancreatoblastoma
Most often occurs in children (mean age 2.5 years), but very rarely affects adults (mean age 40 years)
Poor prognosis: Worse outcomes in adults than children
Large, heterogeneous mass with frequent internal calcifications and necrosis/hemorrhage
No pancreatic or biliary duct obstruction
•
Pancreatic plasmacytoma
Consider in patients with known myeloma
Homogeneous mass without pancreatic/biliary ductal obstruction or pancreatic atrophy
Mimics lymphoma, but usually no lymphadenopathy
•
Pancreatic Lipoma
Benign fat-containing mass (-80 to -120 Hounsfield units) with surrounding capsule
Most often occur in pancreatic head
•
Pancreatic schwannoma
Usually benign, with malignant transformation very rare
Well-circumscribed mass ± cystic degeneration
Can closely mimic neuroendocrine tumors (usually with less avid vascularity)
TOP DIFFERENTIAL DIAGNOSES
•
Pancreatic adenocarcinoma, pancreatic neuroendocrine tumor, lymphoma, mucinous cystic neoplasm
TERMINOLOGY
Abbreviations
•
Anaplastic carcinoma: Pleomorphic carcinoma, undifferentiated carcinoma, sarcomatoid carcinoma
•
Small cell carcinoma: Poorly differentiated carcinoma
•
Giant cell carcinoma: Pancreatic osteoclastoma
Definitions
•
Rare pancreatic malignancies that may mimic adenocarcinomas and neuroendocrine tumors
IMAGING
General Features
•
Anaplastic carcinoma
Large, heterogeneous, moderately enhancing, exophytic mass with necrosis and cystic change
Locally invasive with frequent lung and liver metastases
•
Small cell carcinoma
Large, homogeneous, mildly enhancing mass with confluent local and distant lymphadenopathy
May be indistinguishable from lymphoma
Pancreatic head; homogeneous, hypovascular
•
Giant cell carcinoma (pleomorphic or osteoclast)
Large, heterogeneous, cystic, low-density mass with frequent hemorrhage, septation, and calcification
–
Tendency to arise in pancreatic body and tail
–
Often grow to very large sizes (mean > 6 cm)
Local invasion and distant mets (liver, lung) uncommon
•
Acinar cell carcinoma
Large, well-circumscribed mass with cystic and necrotic degeneration and frequent exophytic component
–
Usually a well-defined enhancing capsule
–
Hypodense on both arterial and venous phases
–
Usually no biliary/pancreatic duct dilatation (even with large tumors)
–
Vascular encasement or occlusion uncommon (20%), and may invade portal vein or SMV
Commonly misdiagnosed as neuroendocrine tumor
No predisposition for any specific location in pancreas
Metastasizes to liver and local lymph nodes
•
Pancreatoblastoma
Can resemble either pancreatic adenocarcinoma or neuroendocrine tumors
Associated with Beckwith-Wiedemann and familial adenomatous polyposis